YOLFTbeta
Delivra Health Brands Inc.

Delivra Health Brands Inc.

DHB · V · Healthcare / Drug Manufacturers - Specialty & Generic

0.09CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.09
Open0.085
Day Range0.085 – 0.09
52-Week Range0.08 – 0.37
Volume4.03K
Market Cap2.50M
P/E (TTM)0.00
Forward P/E3.67
EPS-0.03
Dividend Yield0.00%
Beta0.86
50-Day Avg0.1022
200-Day Avg0.1421

About

Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Gord Davey
  • Employees0
  • Headquarters999 Canada Place, Vancouver, BC, Canada, V6C 3E2, Canada
  • Websitehttps://delivrahealthbrands.com

Leadership

  • Mr. Frank A. Holler MBAIndependent Executive Chairman · b. 1957
  • Mr. Gord DaveyPresident, CEO & Director
  • Mr. Jack Z. Tasse C.M.A., CPACFO & Corporate Secretary
  • Ms. Ann GallerySenior Vice President of Corporate Communications
  • Mr. Tim YoungSenior VP & General Manager
  • Mr. Jonathan David HartshornPresident & CEO of Satipharm · b. 1970

Financials

Income Statement

Currency: CAD2020-06-302021-06-302022-06-302023-06-302024-06-30
Total Revenue7.78M7.96M8.14M9.79M12.38M
Growth (%)-+2.24%+2.30%+20.30%+26.42%
Cost of Revenue7.06M6.04M5.54M4.97M5.98M
Gross Profit724.00K1.92M2.60M4.82M6.40M
Gross Margin9.30%24.12%31.99%49.26%51.70%
Operating Expense16.42M11.18M8.62M6.19M7.11M
Operating Income-15.69M-9.26M-6.01M-1.36M-710.00K
Operating Margin-201.64%-116.39%-73.87%-13.92%-5.74%
EBITDA---4.25M1.40M2.35M
EBITDA Margin---52.28%14.26%19.02%
Net Income-79.86M-28.54M-7.01M-184.00K876.00K
Net Income Margin-1026.18%-358.70%-86.12%-1.88%7.08%
R&D179.00K72.00K0--
R&D as % of Total Revenue2.30%0.90%0.00%--
Interest Expense799.00K-635.00K250.00K169.00K
Interest Expense % of Total Revenue10.27%-7.80%2.55%1.37%

Balance Sheet

Currency: CAD2020-06-302021-06-302022-06-302023-06-302024-06-30
Total Assets57.84M19.06M11.59M10.56M10.05M
Total Liabilities21.27M9.09M8.21M7.17M4.86M
Total Equity33.52M9.98M3.37M3.39M5.19M
Cash1.41M4.43M1.08M2.72M4.20M
Net Debt4.57M-1.02M--

Cash Flow

Currency: CAD2020-06-302021-06-302022-06-302023-06-302024-06-30
Operating Cash Flow-18.36M-9.65M-4.44M-1.09M756.00K
Financing Cash Flow3.17M446.00K-309.00K-255.00K594.00K
Capital Expenditure6.32M33.00K22.00K41.00K0
Free Cash Flow-24.67M-9.68M-4.46M-1.13M756.00K
FCF to OCF134.40%100.34%100.50%103.77%100.00%

Earnings

Report DateOct 28, 2019Oct 6, 2026
EPS Estimate--
EPS Actual-0.04-
Surprise--
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.50M
Enterprise Value3.29M
Trailing P/E0.00
Forward P/E3.67
Price / Sales0.22
Price / Book1.22
EPS-0.03
Book Value0.094
Revenue (TTM)11.24M
Gross Profit (TTM)5.12M
EBITDA-641.00K
Profit Margin-8.99%
Operating Margin-78.43%
Return on Equity-28.27%
Return on Assets-7.61%
Shares Outstanding31.26M
Shares Float24.50M
Beta0.86
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 21, 20251:10